argenx SE
(OTCPK:ARGNF)
$
525.6012
0 (0%)
Market Cap: 33.74 Bil
Enterprise Value: 30.67 Bil
PE Ratio: 0
PB Ratio: 7.89
GF Score: 74/100 argenx SE at TD Cowen Health Care Conference Transcript
Mar 06, 2023 - Mar 08, 2023 / 03:30PM GMT
Release Date Price:
$354
Yaron Benjamin Werber
TD Cowen, Research Division - MD & Senior Biotechnology Analyst
Conference. I'm Yaron Werber from the biotech team. And it's a great pleasure to moderate the panel with argenx with my colleague Brendan Smith. So the management really needs no introduction. We have Tim Van Hauwermeiren, the CEO; and Keith Woods, COO. Gentlemen, thanks so much for joining us. We appreciate it.
Timothy Van Hauwermeiren
argenx SE - CEO & Executive Director
Thanks for having us.
Questions & Answers
Yaron Benjamin Werber
TD Cowen, Research Division - MD & Senior Biotechnology Analyst
So there's a lot to talk about. There's a launch underway that's been going well. There's an upcoming PDUFA for subcu. Their CIDP data coming up, and there's obviously a lot of pipeline data. And Keith, there's obviously news with you that we want to cover.
Let's talk maybe first. The launch has gone very well in the U.S., launch is obviously slower in Europe because of pricing and the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot